≡

Carbonic Anhydrase II (CA2)

[Edit]

CA-II; CAII; Car2; CAC; Carbonate dehydratase II; Carbonic anhydrase C

Carbonic Anhydrase II (CA2)
CCC A782
HGNC 1373
MGI 88269
PubMed 16825953
RGD 2240
UniProt P00918
Wiki CA2

Carbonic anhydrase II (gene name CA2), is one of fourteen forms of humanαcarbonic anhydrases. Carbonic anhydrase catalyzes reversible hydration of carbon dioxide. Defects in this enzyme are associated with osteopetrosis and renal tubular acidosis.

Carbonic anhydrase II is expressed at high levels in osteoclasts during bone resorption. Laitala and Vaananen (1994) demonstrated in 2 in vitro culture systems that antisense RNA and DNA blocked expression of CA II and led to decreased bone resorption. In the choroid plexus, carbonic anhydrase II supports the transport of bicarbonate ions, sodium ions, and water from the blood to the cerebrospinal fluid.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA782Hu01 Recombinant Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
NPA782Hu01 Native Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA782Hu02 Recombinant Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA782Hu04 Recombinant Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
APA782Hu01 Active Carbonic Anhydrase II (CA2) Cell culture; Activity Assays.
Antibodies PAA782Hu01 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
MAA782Hu22 Monoclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
PAA782Hu04 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
PAA782Hu03 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
PAA782Hu02 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
LAA782Hu71 Biotin-Linked Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC.
Assay Kits SEA782Hu ELISA Kit for Carbonic Anhydrase II (CA2) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins NPA782Mu01 Native Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA782Mu01 Recombinant Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA782Mu01 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
LAA782Mu71 Biotin-Linked Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC.
Assay Kits SEA782Mu ELISA Kit for Carbonic Anhydrase II (CA2) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins NPA782Ra01 Native Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA782Ra01 Recombinant Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
APA782Ra01 Active Carbonic Anhydrase II (CA2) Cell culture; Activity Assays.
Antibodies PAA782Ra01 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
PAA782Ra02 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
LAA782Ra71 Biotin-Linked Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC.
Assay Kits SEA782Ra ELISA Kit for Carbonic Anhydrase II (CA2) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Oryctolagus cuniculus (Rabbit)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins NPA782Rb01 Native Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA782Rb51 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
LAA782Rb71 Biotin-Linked Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC.
PAA782Rb01 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Carbonic Anhydrase II (CA2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Carbonic Anhydrase II (CA2) ELISA Kit Customized Service Offer

Organism species: Rhesus monkey (Simian)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA782Si01 Recombinant Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
NPA782Si01 Native Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA782Si01 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
MAA782Si22 Monoclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
LAA782Si91 HRP-Linked Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC.
LAA782Si71 Biotin-Linked Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC.
PAA782Si02 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
MAA782Si21 Monoclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
Assay Kits SEA782Si ELISA Kit for Carbonic Anhydrase II (CA2) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Canis familiaris; Canine (Dog)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins NPA782Ca01 Native Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA782Ca01 Recombinant Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA782Ca01 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
LAA782Ca71 Biotin-Linked Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC.
Assay Kits n/a CLIA Kit for Carbonic Anhydrase II (CA2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Carbonic Anhydrase II (CA2) ELISA Kit Customized Service Offer

Organism species: Ovis aries; Ovine (Sheep)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins NPA782Ov01 Native Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA782Ov01 Recombinant Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA782Ov01 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
LAA782Ov71 Biotin-Linked Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC.
Assay Kits n/a CLIA Kit for Carbonic Anhydrase II (CA2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Carbonic Anhydrase II (CA2) ELISA Kit Customized Service Offer

Organism species: Chicken (Gallus)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA782Ga01 Recombinant Carbonic Anhydrase II (CA2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA782Ga01 Polyclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
MAA782Ga21 Monoclonal Antibody to Carbonic Anhydrase II (CA2) WB; IHC; ICC; IP.
Assay Kits SEA782Ga ELISA Kit for Carbonic Anhydrase II (CA2) Enzyme-linked immunosorbent assay for Antigen Detection.
  1. "Nucleotide sequence of human liver carbonic anhydrase II cDNA."Nucleic Acids Res. 15:4687-4687(1987) [PubMed] [Europe PMC] [Abstract]
  2. "Cloning, expression, and sequence homologies of cDNA for human carbonic anhydrase II."Genomics 1:159-166(1987) [PubMed] [Europe PMC] [Abstract]
  3. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Human carbonic anhydrases. XII. The complete primary structure of the C isozyme."J. Biol. Chem. 249:2329-2337(1974) [PubMed] [Europe PMC] [Abstract]
  6. "Primary structure of human carbonic anhydrase C."J. Biol. Chem. 251:5457-5463(1976) [PubMed] [Europe PMC] [Abstract]
  7. "Comparison of the 5' regions of human and mouse carbonic anhydrase II genes and identification of possible regulatory elements."Biochim. Biophys. Acta 826:195-201(1985) [PubMed] [Europe PMC] [Abstract]
  8. "Direct extracellular interaction between carbonic anhydrase IV and the human NBC1 sodium/bicarbonate co-transporter."Biochemistry 42:12321-12329(2003) [PubMed] [Europe PMC] [Abstract]
  9. "Regulation of the human NBC3 Na+/HCO3- cotransporter by carbonic anhydrase II and PKA."Am. J. Physiol. 286:C1423-C1433(2004) [PubMed] [Europe PMC] [Abstract]
  10. "Molecular mechanism of kNBC1-carbonic anhydrase II interaction in proximal tubule cells."J. Physiol. (Lond.) 559:55-65(2004) [PubMed] [Europe PMC] [Abstract]
  11. "Metabolon disruption: a mechanism that regulates bicarbonate transport."EMBO J. 24:2499-2511(2005) [PubMed] [Europe PMC] [Abstract]
  12. "Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-ray crystal structure of the antiviral drug foscarnet complexed to human carbonic anhydrase I."Bioorg. Med. Chem. Lett. 17:2210-2215(2007) [PubMed] [Europe PMC] [Abstract]
  13. "Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide."Proteins 74:164-175(2009) [PubMed] [Europe PMC] [Abstract]
  14. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  15. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  16. "Crystal structure of human carbonic anhydrase C."Nature New Biol. 235:131-137(1972) [PubMed] [Europe PMC] [Abstract]
  17. "Refined structure of human carbonic anhydrase II at 2.0-A resolution."Proteins 4:274-282(1988) [PubMed] [Europe PMC] [Abstract]
  18. "Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN-ion to the zinc at high pH."Proteins 4:283-293(1988) [PubMed] [Europe PMC] [Abstract]
  19. "Conformational mobility of His-64 in the Thr-200TO: human carbonic anhydrase II."Biochemistry 30:9153-9160(1991) [PubMed] [Europe PMC] [Abstract]
  20. "Engineering the hydrophobic pocket of carbonic anhydrase II."Biochemistry 30:11064-11072(1991) [PubMed] [Europe PMC] [Abstract]
  21. "Altering the mouth of a hydrophobic pocket. Structure and kinetics of human carbonic anhydrase II mutants at residue Val-121."J. Biol. Chem. 266:17320-17325(1991) [PubMed] [Europe PMC] [Abstract]
  22. "Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions."Eur. J. Biochem. 210:867-871(1992) [PubMed] [Europe PMC] [Abstract]
  23. "Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes."J. Mol. Biol. 227:1192-1204(1992) [PubMed] [Europe PMC] [Abstract]
  24. "Structure of cobalt carbonic anhydrase complexed with bicarbonate."J. Mol. Biol. 228:1212-1218(1992) [PubMed] [Europe PMC] [Abstract]
  25. "Engineering the zinc binding site of human carbonic anhydrase II: structure of the His-94-->Cys apoenzyme in a new crystalline form."Biochemistry 32:1510-1518(1993) [PubMed] [Europe PMC] [Abstract]
  26. "Structural consequences of hydrophilic amino acid substitutions in the hydrophobic pocket of human carbonic anhydrase II."Biochemistry 32:4506-4514(1993) [PubMed] [Europe PMC] [Abstract]
  27. "Structure of an engineered His3Cys zinc binding site in human carbonic anhydrase II."Biochemistry 32:9901-9905(1993) [PubMed] [Europe PMC] [Abstract]
  28. "Structure and energetics of a non-proline cis-peptidyl linkage in a proline-202-->alanine carbonic anhydrase II variant."Biochemistry 32:10944-10949(1993) [PubMed] [Europe PMC] [Abstract]
  29. "The structure of human carbonic anhydrase II in complex with bromide and azide."FEBS Lett. 322:186-190(1993) [PubMed] [Europe PMC] [Abstract]
  30. "Structural and functional importance of a conserved hydrogen bond network in human carbonic anhydrase II."J. Biol. Chem. 268:27458-27466(1993) [PubMed] [Europe PMC] [Abstract]
  31. "Crystal structure of the complex between human carbonic anhydrase II and the aromatic inhibitor 1,2,4-triazole."J. Mol. Biol. 232:9-14(1993) [PubMed] [Europe PMC] [Abstract]
  32. "Crystallographic analysis of Thr-200-->His human carbonic anhydrase II and its complex with the substrate, HCO3-."Proteins 15:80-87(1993) [PubMed] [Europe PMC] [Abstract]
  33. "Structural analysis of the zinc hydroxide-Thr-199-Glu-106 hydrogen-bond network in human carbonic anhydrase II."Proteins 17:93-106(1993) [PubMed] [Europe PMC] [Abstract]
  34. "X-ray analysis of metal-substituted human carbonic anhydrase II derivatives."Acta Crystallogr. D 50:93-100(1994) [PubMed] [Europe PMC] [Abstract]
  35. "Wild-type and E106Q mutant carbonic anhydrase complexed with acetate."Acta Crystallogr. D 50:101-104(1994) [PubMed] [Europe PMC] [Abstract]
  36. "Structural consequences of redesigning a protein-zinc binding site."Biochemistry 33:15241-15249(1994) [PubMed] [Europe PMC] [Abstract]
  37. "The structure of a complex between carbonic anhydrase II and a new inhibitor, trifluoromethane sulphonamide."FEBS Lett. 350:319-322(1994) [PubMed] [Europe PMC] [Abstract]
  38. "Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors."Protein Sci. 3:118-125(1994) [PubMed] [Europe PMC] [Abstract]
  39. "Structural basis of inhibitor affinity to variants of human carbonic anhydrase II."Biochemistry 34:3981-3989(1995) [PubMed] [Europe PMC] [Abstract]
  40. "Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants."J. Med. Chem. 38:2286-2291(1995) [PubMed] [Europe PMC] [Abstract]
  41. "Structure-assisted redesign of a protein-zinc-binding site with femtomolar affinity."Proc. Natl. Acad. Sci. U.S.A. 92:5017-5021(1995) [PubMed] [Europe PMC] [Abstract]
  42. "Reversal of the hydrogen bond to zinc ligand histidine-119 dramatically diminishes catalysis and enhances metal equilibration kinetics in carbonic anhydrase II."Biochemistry 35:3439-3446(1996) [PubMed] [Europe PMC] [Abstract]
  43. "X-ray crystallographic studies of alanine-65 variants of carbonic anhydrase II reveal the structural basis of compromised proton transfer in catalysis."Biochemistry 35:16429-16434(1996) [PubMed] [Europe PMC] [Abstract]
  44. "Unexpected binding mode of the sulfonamide fluorophore 5-dimethylamino-1-naphthalene sulfonamide to human carbonic anhydrase II. Implications for the development of a zinc biosensor."J. Biol. Chem. 271:1003-1007(1996) [PubMed] [Europe PMC] [Abstract]
  45. "Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine."Biochemistry 36:10384-10392(1997) [PubMed] [Europe PMC] [Abstract]
  46. "Histidine --> carboxamide ligand substitutions in the zinc binding site of carbonic anhydrase II alter metal coordination geometry but retain catalytic activity."Biochemistry 36:15780-15791(1997) [PubMed] [Europe PMC] [Abstract]
  47. "Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexed with brinzolamide: molecular basis of isozyme-drug discrimination."Protein Sci. 7:556-563(1998) [PubMed] [Europe PMC] [Abstract]
  48. "Structural analysis of inhibitor binding to human carbonic anhydrase II."Protein Sci. 7:2483-2489(1998) [PubMed] [Europe PMC] [Abstract]
  49. "Carbonic anhydrase catalyzes cyanamide hydration to urea: is it mimicking the physiological reaction?"J. Biol. Inorg. Chem. 4:528-536(1999) [PubMed] [Europe PMC] [Abstract]
  50. "Mechanism of cyanamide hydration catalyzed by carbonic anhydrase II suggested by cryogenic X-ray diffraction."Biochemistry 39:12391-12397(2000) [PubMed] [Europe PMC] [Abstract]
  51. "Structural influence of hydrophobic core residues on metal binding and specificity in carbonic anhydrase II."Biochemistry 39:13687-13694(2000) [PubMed] [Europe PMC] [Abstract]
  52. "Structural and kinetic analysis of the chemical rescue of the proton transfer function of carbonic anhydrase II."Biochemistry 40:1741-1748(2001) [PubMed] [Europe PMC] [Abstract]
  53. "Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the crystal lattice of human carbonic anhydrase II."J. Am. Chem. Soc. 123:9620-9627(2001) [PubMed] [Europe PMC] [Abstract]
  54. "Crystal structure of human carbonic anhydrase II complexed with an anti-convulsant sugar sulphamate."Biochem. J. 361:437-441(2002) [PubMed] [Europe PMC] [Abstract]
  55. "Organization of an efficient carbonic anhydrase: implications for the mechanism based on structure-function studies of a T199P/C206S mutant."Biochemistry 41:7628-7635(2002) [PubMed] [Europe PMC] [Abstract]
  56. "Kinetic analysis of multiple proton shuttles in the active site of human carbonic anhydrase."J. Biol. Chem. 277:38870-38876(2002) [PubMed] [Europe PMC] [Abstract]
  57. "Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV."J. Med. Chem. 45:888-893(2002) [PubMed] [Europe PMC] [Abstract]
  58. "Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation."J. Med. Chem. 45:3588-3602(2002) [PubMed] [Europe PMC] [Abstract]
  59. "Combinatorial computational method gives new picomolar ligands for a known enzyme."Proc. Natl. Acad. Sci. U.S.A. 99:1270-1273(2002) [PubMed] [Europe PMC] [Abstract]
  60. "The refined atomic structure of carbonic anhydrase II at 1.05 A resolution: implications of chemical rescue of proton transfer."Acta Crystallogr. D 59:93-104(2003) [PubMed] [Europe PMC] [Abstract]
  61. "Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition."J. Med. Chem. 47:550-557(2004) [PubMed] [Europe PMC] [Abstract]
  62. "Crystal structure of human carbonic anhydrase II at 1.95 A resolution in complex with 667-coumate, a novel anti-cancer agent."Biochem. J. 385:715-720(2005) [PubMed] [Europe PMC] [Abstract]
  63. "Structural and kinetic characterization of active-site histidine as a proton shuttle in catalysis by human carbonic anhydrase II."Biochemistry 44:1097-1105(2005) [PubMed] [Europe PMC] [Abstract]
  64. "First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors."Biochemistry 44:6858-6866(2005) [PubMed] [Europe PMC] [Abstract]
  65. "Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators."Bioorg. Med. Chem. Lett. 15:5136-5141(2005) [PubMed] [Europe PMC] [Abstract]
  66. "Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II."J. Med. Chem. 48:5721-5727(2005) [PubMed] [Europe PMC] [Abstract]
  67. "Proton transfer in a Thr200His mutant of human carbonic anhydrase II."Proteins 61:239-245(2005) [PubMed] [Europe PMC] [Abstract]
  68. "Production and X-ray crystallographic analysis of fully deuterated human carbonic anhydrase II."Acta Crystallogr. F 62:6-9(2006) [PubMed] [Europe PMC] [Abstract]
  69. "X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes."Acta Crystallogr. F 62:618-622(2006) [PubMed] [Europe PMC] [Abstract]
  70. "Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II 'selective' inhibitor celecoxib."Bioorg. Med. Chem. Lett. 16:437-442(2006) [PubMed] [Europe PMC] [Abstract]
  71. "N-hydroxyurea -- a versatile zinc binding function in the design of metalloenzyme inhibitors."Bioorg. Med. Chem. Lett. 16:4316-4320(2006) [PubMed] [Europe PMC] [Abstract]
  72. "Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II."Bioorg. Med. Chem. Lett. 16:6204-6208(2006) [PubMed] [Europe PMC] [Abstract]
  73. "Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme."Chemistry 12:7057-7066(2006) [PubMed] [Europe PMC] [Abstract]
  74. "Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with 'two-prong' inhibitors reveal the molecular basis of high affinity."J. Am. Chem. Soc. 128:3011-3018(2006) [PubMed] [Europe PMC] [Abstract]
  75. "Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX."J. Am. Chem. Soc. 128:8329-8335(2006) [PubMed] [Europe PMC] [Abstract]
  76. "Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design."J. Med. Chem. 49:3019-3027(2006) [PubMed] [Europe PMC] [Abstract]
  77. "Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX."J. Med. Chem. 49:5544-5551(2006) [PubMed] [Europe PMC] [Abstract]
  78. "Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue."J. Med. Chem. 49:7024-7031(2006) [PubMed] [Europe PMC] [Abstract]
  79. "2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity."J. Med. Chem. 49:7683-7696(2006) [PubMed] [Europe PMC] [Abstract]
  80. "Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste."Angew. Chem. Int. Ed. Engl. 46:7697-7699(2007) [PubMed] [Europe PMC] [Abstract]
  81. "Atomic crystal and molecular dynamics simulation structures of human carbonic anhydrase II: insights into the proton transfer mechanism."Biochemistry 46:2930-2937(2007) [PubMed] [Europe PMC] [Abstract]
  82. "Speeding up proton transfer in a fast enzyme: kinetic and crystallographic studies on the effect of hydrophobic amino acid substitutions in the active site of human carbonic anhydrase II."Biochemistry 46:3803-3813(2007) [PubMed] [Europe PMC] [Abstract]
  83. "Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV."Bioorg. Med. Chem. Lett. 17:628-635(2007) [PubMed] [Europe PMC] [Abstract]
  84. "Carbonic anhydrase inhibitors: binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties."Bioorg. Med. Chem. Lett. 17:1726-1731(2007) [PubMed] [Europe PMC] [Abstract]
  85. "Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors."Bioorg. Med. Chem. Lett. 17:2795-2801(2007) [PubMed] [Europe PMC] [Abstract]
  86. "Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides -- solution and crystallographic studies."Bioorg. Med. Chem. Lett. 17:4201-4207(2007) [PubMed] [Europe PMC] [Abstract]
  87. "Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and X-ray crystallographic studies."Bioorg. Med. Chem. Lett. 17:4866-4872(2007) [PubMed] [Europe PMC] [Abstract]
  88. "Location of binding sites in small molecule rescue of human carbonic anhydrase II."Biophys. J. 92:562-570(2007) [PubMed] [Europe PMC] [Abstract]
  89. "Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II."J. Am. Chem. Soc. 129:5528-5537(2007) [PubMed] [Europe PMC] [Abstract]
  90. "Inhibition of carbonic anhydrase II by thioxolone: a mechanistic and structural study."Biochemistry 47:3174-3184(2008) [PubMed] [Europe PMC] [Abstract]
  91. "Role of hydrophilic residues in proton transfer during catalysis by human carbonic anhydrase II."Biochemistry 47:12028-12036(2008) [PubMed] [Europe PMC] [Abstract]
  92. "Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies."Bioorg. Med. Chem. Lett. 18:152-158(2008) [PubMed] [Europe PMC] [Abstract]
  93. "Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies."Bioorg. Med. Chem. Lett. 18:999-1005(2008) [PubMed] [Europe PMC] [Abstract]
  94. "Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct."Bioorg. Med. Chem. Lett. 18:2567-2573(2008) [PubMed] [Europe PMC] [Abstract]
  95. "Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors."Bioorg. Med. Chem. Lett. 18:2669-2674(2008) [PubMed] [Europe PMC] [Abstract]
  96. "Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies."Bioorg. Med. Chem. Lett. 18:4282-4286(2008) [PubMed] [Europe PMC] [Abstract]
  97. "Carbonic anhydrase inhibitors: binding of indanesulfonamides to the human isoform II."ChemMedChem 3:473-477(2008) [PubMed] [Europe PMC] [Abstract]
  98. "Structure of a (129)Xe-cryptophane biosensor complexed with human carbonic anhydrase II."J. Am. Chem. Soc. 130:6942-6943(2008) [PubMed] [Europe PMC] [Abstract]
  99. "Entrapment of carbon dioxide in the active site of carbonic anhydrase II."J. Biol. Chem. 283:30766-30771(2008) [PubMed] [Europe PMC] [Abstract]
  100. "Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents."J. Med. Chem. 51:1295-1308(2008) [PubMed] [Europe PMC] [Abstract]
  101. "Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII."J. Med. Chem. 51:3230-3237(2008) [PubMed] [Europe PMC] [Abstract]
  102. "Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography."Mol. Cancer Ther. 7:2435-2444(2008) [PubMed] [Europe PMC] [Abstract]
  103. "Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties."Biochemistry 48:1322-1331(2009) [PubMed] [Europe PMC] [Abstract]
  104. "Apo-human carbonic anhydrase II revisited: implications of the loss of a metal in protein structure, stability, and solvent network."Biochemistry 48:7365-7372(2009) [PubMed] [Europe PMC] [Abstract]
  105. "A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode alpha-carbonic anhydrases."Bioorg. Med. Chem. Lett. 19:1371-1375(2009) [PubMed] [Europe PMC] [Abstract]
  106. "Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors."J. Am. Chem. Soc. 131:3057-3062(2009) [PubMed] [Europe PMC] [Abstract]
  107. "Carbonic anhydrase inhibitors. Comparison of chlorthalidone and indapamide X-ray crystal structures in adducts with isozyme II: when three water molecules and the keto-enol tautomerism make the difference."J. Med. Chem. 52:322-328(2009) [PubMed] [Europe PMC] [Abstract]
  108. "Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors."J. Med. Chem. 52:5990-5998(2009) [PubMed] [Europe PMC] [Abstract]
  109. "S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases."J. Med. Chem. 52:6421-6432(2009) [PubMed] [
  • An ODM (Original Design Manufacturer) for Assay reagent, Analysis equipment & CRO (Contract Research Organization) for Animal experiment.
  • Tel : 001-832-538-0970 0086-27-8425-9552
  • Fax : 001-832-538-0088 0086-27-8425-9551 Email : mail@cloud-clone.com